Amylyx Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
/ 
Frequently asked questions
To buy Amylyx Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Amylyx Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Amylyx Pharmaceuticals Inc. is AMLX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Amylyx Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Amylyx Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Amylyx Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Amylyx Pharmaceuticals Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Amylyx Pharmaceuticals Inc. or others.